Trial
NCT04496999
HDM201 and Midostaurin (HDMM) in Relapsed/Refractory AML With FLT3mut and TP53wt.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
—
Condition
AML, Adult
Intervention
HDM201
Why stopped
Insufficient recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-06